Old Web
English
Sign In
Acemap
>
authorDetail
>
Hongxiang Wei
Hongxiang Wei
Fujian Medical University
Osteosarcoma
Cancer research
Medicine
PI3K/AKT/mTOR pathway
Cell growth
5
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways.
2021
Journal of Cellular and Molecular Medicine
Zhen Huang
Shenglin Wang
Hongxiang Wei
Hui Chen
Rongkai Shen
Renqin Lin
Xinwen Wang
Wenbin Lan
Rongjin Lin
Jianhua Lin
Show All
Source
Cite
Save
Citations (1)
Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma.
2021
Acta Biochimica et Biophysica Sinica
Shenglin Wang
Hongxiang Wei
Zhen Huang
Wang Xinwen
Rongkai Shen
Zhaoyang Wu
Jianhua Lin
Show All
Source
Cite
Save
Citations (2)
Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway.
2021
Acta Biochimica et Biophysica Sinica
Shenglin Wang
Yunqing Wang
Zhen Huang
Hongxiang Wei
Xinwen Wang
Rongkai Shen
Wenbin Lan
Guang-Xian Zhong
Jianhua Lin
Show All
Source
Cite
Save
Citations (0)
Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma.
2021
Frontiers in Pharmacology
Zhen Huang
Hui Chen
Shenglin Wang
Hongxiang Wei
Xinwen Wang
Rongkai Shen
Yunqing Wang
Rongjin Lin
Jianhua Lin
Show All
Source
Cite
Save
Citations (0)
Gasdermin D expression and clinicopathologic outcome in primary osteosarcoma patients.
2020
International Journal of Clinical and Experimental Pathology
Rong-Jin Lin
Hongxiang Wei
Shenglin Wang
Zhen Huang
Hui Chen
Shaoying Zhang
Jianhua Lin
Guang-Xian Zhong
Show All
Source
Cite
Save
Citations (4)
1